Cerebrospinal fluid penetration of very high-dose meropenem: a case report
Abstract Background Standard dosing of meropenem (2 g t.i.d.) produces CSF concentrations of only 1-2 mg/L which is inferior to the clinical breakpoint for most Gram-negative bacteria. There is therefore concern that dosing must be increased in order to achieve therapeutic CSF concentrations for bac...
Saved in:
Main Authors: | Thomas Kerz (Author), Friederike D. von Loewenich (Author), Jason Roberts (Author), Axel Neulen (Author), Florian Ringel (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid
by: Eric H. Decloedt, et al.
Published: (2021) -
Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
by: Christoph Tiede, et al.
Published: (2021) -
Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study
by: Christina König, et al.
Published: (2023) -
Cerebrospinal Fluid
Published: (2022) -
Cerebrospinal Fluid and Brain Tissue Penetration of Tenofovir, Lamivudine, and Efavirenz in Postmortem Tissues with Cryptococcal Meningitis
by: Melanie R. Nicol, et al.
Published: (2019)